MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaci.2024.03.030

Медицинская библиотека · The Journal of allergy and clinical immunology · 2024

PEGylated liposomes for diagnosis of polyethylene glycol allergy.

Perkins Griffith B, Tunbridge Matthew J, Hurtado Plinio R, Zuiani James, Mhatre Shweta, Yip Kwok Ho, Le Thanh-Thao Adriana, Yuson Carlo, Kette Frank, Hissaria Pravin

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Polyethylene glycol (PEG) is a nonprotein polymer that is present in its native (unbound) form as an excipient in a range of products. It is increasingly being utilized clinically in the form of PEGylated liposomal medications and vaccines. PEG is the cause of anaphylaxis in a small percentage of drug reactions; however, diagnosis of PEG allergy is complicated by the variable and poor diagnostic performance of current skin testing protocols.

OBJECTIVE

We assessed the diagnostic performance of PEGylated lipid medications as an alternative to currently described tests that use medications containing PEG excipients.

METHODS

Nine patients with a strong history of PEG allergy were evaluated by skin testing with a panel of PEG-containing medications and with a PEGylated lipid nanoparticle vaccine (BNT162b2). Reactivity of basophils to unbound and liposomal PEG was assessed ex vivo, and specificity of basophil responses to PEGylated liposomes was investigated with a competitive inhibition assay. More detailed information is provided in this article's Methods section in the Online Repository available at www.jacionline.org.

RESULTS

Despite compelling histories of anaphylaxis to PEG-containing medications, only 2 (22%) of 9 patients were skin test positive for purified PEG or their index reaction-indicated PEG-containing compound. Conversely, all 9 patients were skin test positive or basophil activation test positive to PEGylated liposomal BNT162b2 vaccine. Concordantly, PEGylated liposomal drugs (BNT162b2 vaccine and PEGylated liposomal doxorubicin), but not purified PEG2000, consistently induced basophil activation ex vivo in patients with PEG allergy but not in nonallergic controls. Basophil reactivity to PEGylated nanoparticles competitively inhibited by preincubation of basophils with native PEG2000.

CONCLUSION

Presentation of PEG on the surface of a lipid nanoparticle increases its in vivo and ex vivo allergenicity, and improves diagnosis of PEG allergy.

Для цитирования: Perkins Griffith B, Tunbridge Matthew J, Hurtado Plinio R, Zuiani James, Mhatre Shweta, Yip Kwok Ho, Le Thanh-Thao Adriana, Yuson Carlo, Kette Frank, Hissaria Pravin. PEGylated liposomes for diagnosis of polyethylene glycol allergy.. The Journal of allergy and clinical immunology. 2024. DOI: 10.1016/j.jaci.2024.03.030.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.